View Older Stories View More Recent Stories

May 7, 2018 08:30AM ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
Apr 30, 2018 05:44AM ANI Pharma (ANIP) Agrees to Acquire Generic Products & Other Assets from Amneal Pharmaceuticals LLC and Impax Laboratories Inc. (IPXL)
Apr 27, 2018 06:30PM ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax
Apr 18, 2018 08:31AM ANI Pharma (ANIP) Receives FDA Approval of Morphine Sulfate Oral Solution
Apr 18, 2018 08:30AM ANI Pharmaceuticals Announces Approval of Morphine Sulfate Oral Solution
Apr 4, 2018 08:32AM ANI Pharma (ANIP) Buys 23 ANDAs from IDT Australia, Ltd.
Apr 4, 2018 08:30AM ANI Acquires 23 ANDAs from IDT Australia, Ltd.
Mar 2, 2018 08:30AM ANI Pharmaceuticals to Present at the Raymond James 39th Annual Institutional Investors Conference
Feb 27, 2018 08:30AM ANI Pharmaceuticals Reports Record Full Year Results, Reports Fourth Quarter 2017 Results, and Provides 2018 Guidance
Dec 29, 2017 09:26AM ANI Pharmaceuticals Enters Five-Year $125 Million Senior Secured Credit Facility with Citizens Bank
Dec 29, 2017 09:23AM ANI Pharma (ANIP) Acquires U.S. Rights to Four NDAs from AstraZeneca (AZN) for $46.5M
Dec 29, 2017 09:21AM ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million
Nov 2, 2017 08:30AM ANI Pharmaceuticals Reports Record Third Quarter and Year-To-Date 2017 Results and Narrows Full Year Guidance
Sep 1, 2017 08:59AM ANI Pharma (ANIP) Reports FDA Approval and Launch of Oxycodone Hydrochloride Oral Solution 100 mg/5mL
Sep 1, 2017 08:30AM ANI Pharmaceuticals Announces Approval and Launch of Oxycodone Hydrochloride Oral Solution, 100 mg/5mL
Aug 8, 2017 08:30AM ANI Pharmaceuticals to Present at the Canaccord Genuity 37th Annual Growth Conference
Aug 3, 2017 08:30AM ANI Pharmaceuticals Reports Record Second Quarter and Year-To-Date 2017 Results and Reaffirms Guidance
Jun 20, 2017 08:31AM ANI Pharma (ANIP) Reports Launch of Diphenoxylate HCl, Atropine Sulfate Tablets
Jun 20, 2017 08:30AM ANI Pharmaceuticals Announces Launch of Diphenoxylate HCl and Atropine Sulfate Tablets
May 8, 2017 09:15AM ANI Pharmaceuticals Announces Launch of Pindolol Tablets
May 4, 2017 08:30AM ANI Pharmaceuticals Reports First Quarter Results and Year-To-Date 2017 Highlights and Reaffirms Guidance
Apr 19, 2017 08:31AM ANI Pharma (ANIP) Launches Indapamide Tablets
Apr 19, 2017 08:30AM ANI Pharmaceuticals Announces Launch of Indapamide Tablets
Mar 2, 2017 08:30AM ANI Pharmaceuticals Reports Full Year 2016 Results and Fourth Quarter Results and Provides 2017 Guidance
Feb 24, 2017 08:31AM ANI Pharma (ANIP) Buys Inderal XL and InnoPran XL
Feb 24, 2017 08:30AM ANI Pharmaceuticals Acquires Inderal® XL and InnoPran XL®
Jan 17, 2017 08:30AM ANI Announces Appointment of Karen Quinn Ph.D as Vice President Corticotropin Regulatory Affairs
Dec 21, 2016 08:33AM ANI Pharma (ANIP) Announces Launches of Generic of Lithobid
Dec 21, 2016 08:30AM ANI Pharmaceuticals Announces Launch of Authorized Generic of Lithobid® Extended Release Tablets
Dec 20, 2016 08:35AM ANI Pharma (ANIP) Launches Vancomycin HCl 125mg and 250mg Capsules in 50 Count Bottle
Dec 20, 2016 08:30AM ANI Pharmaceuticals Announces Launch of Vancomycin Capsules in 50 Count Bottle
Nov 3, 2016 08:30AM ANI Pharmaceuticals Reports Record Third Quarter Results and Year-To-Date 2016 Highlights and Narrows Full-year Guidance
Oct 25, 2016 08:30AM ANI Pharma (ANIP) Launches Benztropine Mesylate Tablets
Oct 25, 2016 08:30AM ANI Pharmaceuticals Announces Launch of Benztropine Mesylate Tablets USP
Sep 27, 2016 08:30AM ANI Pharmaceuticals Announces Launch of Erythromycin Ethylsuccinate for Oral Suspension, 200mg/5mL
Aug 4, 2016 08:30AM ANI Pharmaceuticals Reports Record Second Quarter Results and Increases Full-year 2016 Guidance
Jul 18, 2016 08:34AM ANI Pharma (ANIP) Receives FDA Approval for Nilutamide Tabs ANDA
Jul 18, 2016 08:30AM ANI Pharmaceuticals Announces FDA Approval and Immediate Launch of Nilutamide Tablets, the First Generic Competitor to Nilandron®
Jun 28, 2016 08:35AM ANI Pharma (ANIP) Announces Commercial Launch of HPC USP 250mg/mL in 5mL Vials
Jun 28, 2016 08:30AM ANI Pharmaceuticals Announces Launch of Hydroxyprogesterone Caproate Injection USP, 250mg/mL
Jun 13, 2016 08:06AM ANI Pharma (ANIP) Receives FDA Approval of Oxcarbazepine Tabs PAS
Jun 13, 2016 08:05AM ANI Pharmaceuticals Announces FDA Approval of Oxcarbazepine Tablets
Jun 13, 2016 08:00AM ANI Pharmaceuticals Announces Launch of Oxycodone Capsules, 5mg
May 23, 2016 08:30AM ANI Announces Appointment of Mark J. Ginski Ph.D as Vice President Corticotropin Product Development
May 18, 2016 08:00AM ANI Pharmaceuticals to Present at the UBS Global Healthcare Conference
May 17, 2016 09:00AM ANI Pharmaceuticals Enters Into Exclusive Distribution and Supply Agreement for Hydroxyprogesterone Caproate Injection USP
May 16, 2016 09:15AM ANI Pharmaceuticals Launches Authorized Generic of Rowasa® Enema 4g/60mL
May 13, 2016 09:00AM ANI Pharmaceuticals Enters Three Year $30 Million Asset Based Line of Credit with Citizens Bank
May 9, 2016 08:00AM ANI Pharmaceuticals Announces Launch of 50mg and 150mg Fenofibrate Capsules in ANI label
May 5, 2016 08:00AM ANI Pharmaceuticals Reports First Quarter Results and Year-To-Date 2016 Highlights and Reaffirms Updated Guidance
View More Recent Stories View Older Stories